药品可及性评价指标体系研究  

Study on Evaluation Indicator System of Drug Accessibility

作　　者：龚时薇[1] 许燚[1] 张亮[2] 

机构地区：[1]华中科技大学同济医学院药学院,武汉430030 [2]华中科技大学同济医学院医药卫生管理学院,武汉430030

出　　处：《中国卫生经济》2011年第5期72-74,共3页Chinese Health Economics

基　　金：国家自然科学基金青年基金资助项目(70903025);华中科技大学自主创新研究基金资助项目(Q2009041)

摘　　要：药品可及性是评价医药卫生系统满足人们用药需求程度的重要指标之一。通过文献研究和理论分析,探索评价药品可及性的三级评价指标体系。研究表明药品的可及性指标包括药品的可获得性、可供应性、可利用性、可负担性和用药及时性五大方面,覆盖疾病类型、药品品种、数量、信息、成本、技术、时间、空间8个维度。因此,提高我国药品的可及性是一项系统工程,需要在药品的研究、生产、经营、使用、定价和保险等众多领域建立共识与合作。Drug accessibility is an important evaluation indicator that measures health system performance in meeting people＇s need for drugs.Based on literature research method and theory analysis,three levels of evaluation indicator system of drug accessibility are explored.The study shows the evaluation indicator system of drug accessibility includes drug availability,good supply,utilizable,affordable and responsiveness ability.The issues of drug accessibility cover eight aspects,including disease type,drug type,drug number,drug information,drug cost,science and technology level,time and space.So improving drug accessibility is a system project.We should set up common view and cooperation in drug many fields,such as RD,manufacture,supply,use,pricing and insurance.

关 键 词：药品可及性 系统反应性 评价指标 

分 类 号：R95[医药卫生—药学]